Table 2 Indicators of the prothrombotic state
Indicator (reference range) | MINOCA, n = 16 | MICAD, n = 21 | p-value |
|---|---|---|---|
Protein C, % (70–130) | 111.6 (101.9;120.1) | 127 (122.3;132,2) | 0.36 |
Protein C deficiency, < 70% | 2(12.5) | 2 (9.5) | 0.91 |
Antithrombin, % (83–128) | 101.6 (96.6;110.2) | 124 (119.0;129.2) | 0.86 |
Antithrombin deficiency, n% | 2 (12,5) | 0 | 0.10 |
Willebrand factor, % (69–116) | 106.5 (90.0;116.0) | 117 (114.3;118.7) | 0.35 |
Willebrand factor deficiency, n% | 6 (37.5) | 7 (33.3) | 0.10 |
Homocysteine, mcmol/L (4,1–10,2) | 12.1 (11.0;14.0) | 10.4 (8.7;12.5) | 0.03 |
Hyperhomocysteinemia, n% | 9 (56.3) | 5 (23.8) | 0.04 |
Plasminogen, % (80–135) | 113.1 (101.3;119.8) | 122.0 (115.2;127.1) | 0.007 |
Plasminogen deficiency, n% | 3 (18.8) | 1 (4.8) | 0.23 |
IgG antibodies to cardiolipin, n% | 0 | 0 | – |
IgM antibodies to cardiolipin, n% | 2 (25) | 2 (9.5) | 0.62 |
IgG antibodies to β2-glycoprotein, n% | 0 | 0 | – |
IgM antibodies to β2-glycoprotein-I, n% | 2 (25) | 2 (9.5) | 0.65 |
Lupus anticoagulant, n% | 9 (56.2) | 11(52.3) | 0.62 |